Ursula A. Matulonis, MD, and Jacob Korach, MD, on AML Risk in Ovarian Cancer: Results From the SOLO2 Trial from solo2 Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Ursula A. Matulonis, MD, of Dana-Farber Cancer Institute, and Jacob Korach, MD, of Sheba Medical Center, Tel Aviv University, discuss study findings on the incidence of myelodysplastic syndrome and acute myeloid leukemia in patients with platinum-sensitive relapsed ovarian cancer receiving maintenance olaparib.
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)